The latest analyst coverage could presage a bad day for BioNTech SE (NASDAQ:BNTX), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little ...
In a big breakthrough for cancer treatment, Dr. Vinod Balachandran, a surgeon-scientist at Memorial Sloan Kettering Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback